FIELD: medicine. SUBSTANCE: course dose of antitumor chemopreparations: cyclophosphane, ThioTEPA, methotrexat is dissolved in ascitic fluid of patient, solution is kept for 4 hr on water bath at 37 C and administrated again into the peritoneal cavity of patient. EFFECT: absence of general toxic action, ceasation of ascitic fluid accumulation, decreased tumor growth. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MALIGNANT TUMOR CHEMOTHERAPY | 1989 |
|
RU2057528C1 |
| METHOD OF TREATMENT OF PATIENTS WITH OVARIAN CANCER | 2007 |
|
RU2352341C1 |
| METHOD FOR TREATING BILATERAL TUMOR PLEURITIS | 2002 |
|
RU2225231C1 |
| METHOD FOR TREATING OVARY CANCER | 1999 |
|
RU2163152C1 |
| METHOD FOR TREATMENT OF ABDOMINAL CAVITY PRIMARY AND METASTATIC TUMORS | 2003 |
|
RU2272655C2 |
| METHOD FOR TREATING CANCER OF UTERINE BODY | 2000 |
|
RU2195268C2 |
| METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO CHEMOTHERAPY IN PATIENTS SUFFERING FROM ASCITIC FORM OF III-IV STAGE OVARIAN CARCINOMA | 1999 |
|
RU2161801C2 |
| METHOD FOR PREOPERATIVE TREATMENT OF RECTUM CANCER | 1993 |
|
RU2085200C1 |
| METHOD FOR TREATING THE CASES OF MAMMALIAN GLAND CARCINOMA | 2001 |
|
RU2203687C2 |
| METHOD FOR SIGHTING INTRAORGANIC CHEMOTHERAPY IN PATIENTS WITH UTERINE BODY CANCER | 2002 |
|
RU2222261C2 |
